SCHEMBL7697154

SCHEMBL7697154

Cc1ccc(CNC(=O)C2CCC(Cc3nc4ccccc4[nH]3)CC2)cc1

nearest known ligand 0.62

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.54
SMN1; SMN2 Q16637 2/20 0.52
TP53 P04637 2/20 0.51
RXFP1 Q9HBX9 1/20 0.51
PKM P14618 1/20 0.50
NTRK1 P04629 1/20 0.50
IDO1 P14902 1/20 0.49
KMT2A Q03164 2/20 0.48
NPC1 O15118 1/20 0.48
RAB9A P51151 1/20 0.48
FPR3 P25089 1/20 0.47
FPR2 P25090 1/20 0.47
MEN1 O00255 1/20 0.47
GRIN2B Q13224 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7695913 1.00 LMNA (0.54) LMNASMN1; SMN2TP53RXFP1PKM
SCHEMBL7692588 1.00 LMNA (0.54) LMNASMN1; SMN2TP53RXFP1PKM
SCHEMBL7682709 0.91 IDO1 (0.56) SMN1; SMN2TP53PKMIDO1FPR3
SCHEMBL7083207 0.91 IDO1 (0.56) SMN1; SMN2TP53PKMIDO1FPR3
SCHEMBL7083210 0.91 IDO1 (0.56) SMN1; SMN2TP53PKMIDO1FPR3
SCHEMBL7692347 0.90 MEN1 (0.53) LMNASMN1; SMN2TP53PKMIDO1
SCHEMBL7693251 0.90 MEN1 (0.53) LMNASMN1; SMN2TP53PKMIDO1
SCHEMBL7697393 0.90 MEN1 (0.53) LMNASMN1; SMN2TP53PKMIDO1
SCHEMBL7696663 0.89 MAPT (0.55) LMNASMN1; SMN2TP53PKMNTRK1
SCHEMBL7695566 0.89 MAPT (0.55) LMNASMN1; SMN2TP53PKMNTRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6291499-B1 TREATING MIGRAINE, DEPRESSION, ANXIETY, SCHIZOPHRENIA, PARKINSON'S DISEASE, OR STROKE MERCK & CO., INC. 2001-09-18 US claimed
US-6380205-B1 QUINAZOLINE THROUGH A C1-C4ALKYL, C1- C4ALKENYL, C1-C4ALKYNYL, C1-C4ALKOXY, AMINO, AMINOC1-C4ALKYL, HYDROXYC1-C4ALKYL, CARBONYL, CYCLOC3-C6ALKYL OR AMINOCARBONYL CHAIN, USEFUL FOR TREATMENT OF THE PAIN MERCK & CO., INC. 2002-04-30 US disclosed
US-6291499-B1 TREATING MIGRAINE, DEPRESSION, ANXIETY, SCHIZOPHRENIA, PARKINSON'S DISEASE, OR STROKE MERCK & CO., INC. 2001-09-18 US disclosed